Clustering analysis of PCBs and their metabolites using the ToxPi. (A) Color diagram for data integration into pie chart slices for each type of analysis (in vitro toxicity data, physicochemical properties, and combination of the two). (B) Clustering using in vitro data where point-of-departures values derived from 30 phenotypic assays were grouped into eight categories (iPSC-CMs’ physiological responses and cellular toxicity after 90 min and 24 h, and iPSC-ECs’ and HUVECs’ tubulogenesis and cellular toxicity data). A summary of point-of departure values is shown in the Supplemental Excel file, tab POD summary. (C) Calculated physicochemical descriptors were used for the generation of ToxPi and clustering. (D) Clustering based on a combination of in vitro and physicochemical data. In ToxPi images, each slice is a representation of cell type- and time-point-specific phenotypes or scaled values associated with a physicochemical characteristic, the area of each slice is proportional to the relative value of the effect for a given chemical within the dataset. Each ToxPi is corresponding to one compound tested in this study. Chemical names and abbreviations of PCBs and metabolites are listed in Table S1. Data for each ToxPi are available in the Supplemental Excel file, tab ToxPi_summary. Note: CMs, cardiomyocytes; ECs, endothelial cells; HUVECs, human umbilical vein endothelial cells; iPSC, induced pluripotent stem cell; iPSC-CMs, iPSC cardiomyocytes; PCBs, polychlorinated biphenyls; ToxPi, Toxicological Prioritization Index.